favipiravir

CAS: 259793-96-9

MF: C5H4FN3O2

MW: 157.1

EINECS: 1533716-785-6

density 1.78±0.1 g/cm3(Predicted)

Favipiravir is a broad-spectrum antiviral drug.

Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.